Cancers are characterized by growth and spread of abnormal cells. If uncontrolled growth of abnormal cells starts in a woman’s reproductive organs such as the cervix or the ovaries, it is called gynecological cancer. Several factors are responsible for occurrence of gynecological cancer. Cancer-originating genes, also called oncogenes, are primarily responsible for abnormal growth of cells. Infertility, obesity, mutations, smoking, environmental influences, and early onset of menstruation are some of the factors causing gynecological cancers. Gynecological cancers are also caused by viruses such as human papillomavirus that causes cervical cancer and vulvar cancer. Several women do not manifest symptoms in the initial stages of cancer. However, in the later stages, vaginal discharge, pain, and bleeding during intercourse are observed. There are several methods to treat gynecological cancers and the treatment depends on the type of cancer and how far it has spread. Regular screening and self-examination can be helpful for early detection of cancer.
Based on type of cancer, the global gynecological cancers market can be segmented into uterine cancer, ovarian cancer, cervical cancer, vaginal cancer, and vulvar cancer. The uterine cancer segment is likely to expand at a significant pace during the forecast period, due to growing prevalence of obesity. Obese women have high levels of estrogen as compare to progesterone, which increases the risk of developing uterine cancer. In terms of treatment, the gynecological cancers market can be segregated into surgery, chemotherapy, radiation therapy, and others. The surgery segment is expected to expand at a significant pace from 2017 to 2025, as surgery is the immediate invasive procedure that involves removal of the damaged cells or tissues from the effected organ. Increasing incidence of cancer, especially uterine cancer and ovarian cancer, across the world is a primary factor driving the global gynecological cancers market. Growing number of smokers and rising prevalence of obesity have led to high incidence of different gynecological cancers. Moreover, initiatives by various governments to raise awareness about cancer is promoting the growth of the global gynecological cancers market. However, patent expiry of certain drugs, longer recovery process, low level or lack of reimbursements in developing countries are factors restraining the market in these countries.
In terms of region, the global gynecological cancers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. It is projected to hold a significant share of the global market between 2017 and 2025, due to increase in the prevalence of gynecological cancers in the region. According to the American Cancer Society, in 2014, a total of 52,630 new cases of uterine cancer were reported and, in 2015, the number of patients increased to 54,870. In Europe, lifestyle factors such as obesity, lack of physical activity, and hormone replacement therapy have led to increasing prevalence of uterine cancer. According to Cancer Research UK, about 37% of uterine cancers are caused by obesity. This propels the market for gynecological cancers in Europe. Growth of the health care sector, increasing awareness among people about gynecological cancers and their effects, and rise in geriatric population are key factors boosting the market for gynecological cancers in Asia Pacific. Advancements in diagnostic techniques, increasing per capita income, improving quality of life, and growing incidence of cervical cancer in Africa are likely to augment the market for gynecological cancers in Middle East & Africa during the forecast period.
Major players operating in the global gynecological cancers market are Becton Dickinson and Co., Bristol Myers Squibb Co., Merck & Co., Pfizer, GlaxoSmithKline plc, Eli Lilly and Co., and F. Hoffmann La Roche Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.